53 research outputs found
The Effects of N-Heterocyclic Ligands on the Nature of the Ruâ(NO) Bond in Ruthenium Tetraammine Nitrosyl Complexes
Quantum chemical calculations at the DFT level have been carried out to analyze quantitatively the RuIIâ(NO)+, RuIIIâ(NO)0 and RuIIâ(NO)0 bonds in trans-[RuII(NH3)4(L)(NO)]q and trans-[RuII(NH3)4(L)(NO)]qâ1 complexes, where L = 4-picoline (4-pic), C-bound imidazole (imC), N-bound imidazole (imN), nicotinamide (nic), pyridine (py), and pyrazine (pz). Equilibrium geometries and the vibrational frequencies are reported for the ground state GS and light-induced metastable states, MS1 and MS2, presenting good agreement with the experimental data. The nature of the RuIIâ(NO)+ and RuIIâ(NO)0 bonds was investigated by means of the energy decomposition analysis, EDA. The Ruâ(NO) bonding situation has been analyzed in two different situations: prior and after one-electron reduction at the NO+ group. The EDA results for the complexes prior to the reduction of the NO+ indicate that the metalligand Ï-orbital interactions between NO+ and the [RuII(NH3)4(L)]qâ1 are the most important term and that the trans-ligands imN and nic contribute to an increase in the Ï-donor strength of the metal centre towards NO+. For RuIIIâ(NO)0 bonds, the smallest values of ÎEint, ÎEPauli, ÎEelstat, and De are observed when L = imC or L = nic, independent of the state under consideration, GS or MS1, indicating that when L = imC or nic the RuIIIâ(NO)0 bond in GS or in MS1 states is more labile. After the reduction of the NO+ group, the RuIIâ(NO)0 becomes more labile when the trans-ligand is imC, which agrees with the experimental rate constants of NO0 dissociation
Solvation Enhances the Distinction Between Carboxylated Armchair and Zigzag Single-Wall Carbon Nanotubes (SWNT-COOH)
The effect of various solvents on the structures and properties of carboxylated SWNTs has been explored using the Same Level Different Basis Set approach (SLDB), where B3LYP functional of density functional theory (DFT) was applied. Armchair (4,4) and zigzag (8,0) and (9,0) tubes were considered as the test bed. In order to simulate varying concentration of âCOOH groups, one to five acids groups were placed at one end of these tubes. These samples were placed in different solvents (namely, CS2, THF and water) with varying polarity and results were compared with gas-phase properties. Similar to the gas-phase, zigzag tubes also exhibit both regular (r-COOH, v(C=O) above 1700 cm-1) and low-frequency (lf-COOH, v(C=O) below 1700 cm-1) acid groups. Characteristics of r-COOH group are not affected much in solvents, but lf-COOH of the zigzag tube is the one that makes these tubes distinguishable from its armchair cousin. Stability and charge distribution of SWNT-COOH strongly depend on the number of acid groups in different solvents which may help controlling further functionalization. Vibrational analyses reveal certain features in the 1400-1600 cm-1 range that are characteristic of lf-COOH in different solvents, which may help in the assignment of experimental spectra of oxidized SWNT in solvents
Platinum-Triggered Bond-Cleavage of Pentynoyl Amide and N-Propargyl Handles for Drug-Activation.
The ability to create ways to control drug activation at specific tissues while sparing healthy tissues remains a major challenge. The administration of exogenous target-specific triggers offers the potential for traceless release of active drugs on tumor sites from antibody-drug conjugates (ADCs) and caged prodrugs. We have developed a metal-mediated bond-cleavage reaction that uses platinum complexes [K2PtCl4 or Cisplatin (CisPt)] for drug activation. Key to the success of the reaction is a water-promoted activation process that triggers the reactivity of the platinum complexes. Under these conditions, the decaging of pentynoyl tertiary amides and N-propargyls occurs rapidly in aqueous systems. In cells, the protected analogues of cytotoxic drugs 5-fluorouracil (5-FU) and monomethyl auristatin E (MMAE) are partially activated by nontoxic amounts of platinum salts. Additionally, a noninternalizing ADC built with a pentynoyl traceless linker that features a tertiary amide protected MMAE was also decaged in the presence of platinum salts for extracellular drug release in cancer cells. Finally, CisPt-mediated prodrug activation of a propargyl derivative of 5-FU was shown in a colorectal zebrafish xenograft model that led to significant reductions in tumor size. Overall, our results reveal a new metal-based cleavable reaction that expands the application of platinum complexes beyond those in catalysis and cancer therapy.EPSRC studentship for Benjamin Stenton
Recommended from our members
Synthesis, characterization and photoinduced CO-release by manganese(i) complexes
Herein, we report the CO-release activity of three new photoCORMs, two with nonbonding pyridine moieties and one with a benzyl group. The compounds [MnBr(CO)3(bpa-Îș2)] (2, where bpa = N-benzyl(2-pyridylmethyl)amine); [MnBr(CO)3(pmpeaÎș2)] (3, where pmpea = N-(2-pyridylmethyl)-Nâ-(2-pyridylethyl)amine) and [MnBr(CO)3(bpea-Îș2)] (4, where bpea = N-bis(2- pyridylethyl)amine) were synthesized and characterized by common spectroscopic techniques (UV-Vis, IR). Density functional theory studies were also performed to provide new insights into the MâC bond and to assume the orbitals involved in the absorption transitions. Their CO-release activities were measured both in organic and in physiological media and compared to that of a previously published compound [Mn(CO)3(dpa-Îș3)]Br (1, where dpa = N-bis(2- pyridylmethyl)amine). An increase in the number of members of the chelate from five to six, influenced the release of CO, affecting both the binding mode of the ligand and the CO-release process and affecting their potential use as potentials CO release carriers as therapeutic agents
Convergent Sets of Data from In Vivo and In Vitro Methods Point to an Active Role of Hsp60 in Chronic Obstructive Pulmonary Disease Pathogenesis
BACKGROUND: It is increasingly clear that some heat shock proteins (Hsps) play a role in inflammation. Here, we report results showing participation of Hsp60 in the pathogenesis of chronic obstructive pulmonary diseases (COPD), as indicated by data from both in vivo and in vitro analyses.
METHODS AND RESULTS: Bronchial biopsies from patients with stable COPD, smoker controls with normal lung function, and non-smoker controls were studied. We quantified by immunohistochemistry levels of Hsp10, Hsp27, Hsp40, Hsp60, Hsp70, Hsp90, and HSF-1, along with levels of inflammatory markers. Hsp10, Hsp40, and Hsp60 were increased during progression of disease. We found also a positive correlation between the number of neutrophils and Hsp60 levels. Double-immunostaining showed that Hsp60-positive neutrophils were significantly increased in COPD patients. We then investigated in vitro the effect on Hsp60 expression in bronchial epithelial cells (16HBE) caused by oxidative stress, a hallmark of COPD mucosa, which we induced with H\u2082O\u2082. This stressor determined increased levels of Hsp60 through a gene up-regulation mechanism involving NFkB-p65. Release of Hsp60 in the extracellular medium by the bronchial epithelial cells was also increased after H\u2082O\u2082 treatment in the absence of cell death.
CONCLUSIONS: This is the first report clearly pointing to participation of Hsps, particularly Hsp60, in COPD pathogenesis. Hsp60 induction by NFkB-p65 and its release by epithelial cells after oxidative stress can have a role in maintaining inflammation, e.g., by stimulating neutrophils activity. The data open new scenarios that might help in designing efficacious anti-inflammatory therapies centered on Hsp60 and applicable to COP
Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial
Background: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials.
Patients and Methods: The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate >= 25 mL/min/1.73 m(2) and albuminuria (urinary albumin-to-creatinine ratio >= 30 to <= 5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level alpha = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure.
Conclusions: FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen.
Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049
Qual o sĂtio de reação? Um experimento computacional
A computational quantum chemistry experiment is described on the determination of the most reactive atom in a molecule for a reaction. The reaction studied was the S N2 of 4-(dimethylamino)pyridine and methyl iodide. Several indexes (HOMO coefficent, (c), charges, (q), nucleophilic softness, (s+), and Fukui index, (f+)) were employed to verify which correctly describe what nitrogen will react. The calculations were made by AM1 and HF/STO-3G methods. The correct reactivity order is only reproduced by s+ and f+. The lack of agreement of FMO based indexes was discussed
A Computational Study of Tetrafluoro-[2.2]Cyclophanes
A computational study of the isomers of tetrafluorinated [2.2]cyclophanes persubstituted in one ring, namely F-4-[2.2]paracyclophane (4), F-4-anti-[2.2]metacyclophane (5a), F-4-syn-[2.2]metacyclophane (5b), and F-4-[2.2]metaparacyclophane (6a and 6b), was carried out. The effects of fluorination on the geometries, relative energies, local and global aromaticity, and strain energies of the bridges and rings were investigated. An analysis of the electron density by B3PW91/6-31+G(d,p), B3LYP/6-31+G(d,p), and MP2/6-31+G(d,p) was carried out using the natural bond orbitals (NBO), natural steric analysis (NSA), and atoms in molecules (AIM) methods. The analysis of frontier molecular orbitals (MOs) was also employed. The results indicated that the molecular structure of [2.2]paracyclophane is the most affected by the fluorination. Isodesmic reactions showed that the fluorinated rings are more strained than the nonfluorinated ones. The NICS, HOMA, and PDI criteria evidenced that the fluorination affects the aromaticity of both the fluorinated and the nonfluorinated rings. The NBO and NSA analyses gave an indication that the fluorination increases not only the number of through-space interactions but also their magnitude. The AIM analysis suggested that the through-space interactions are restricted to the F-4-[2.2]metacyclophanes. In addition, the atomic properties, computed over the atomic basins, shave evidence that not only the substitution, but also the position of the bridges could affect the atomic charges. the first atomic moments, and the atomic volumes.FAPESP[02/03753-5]CAPESCNPq[452292/2005-0
- âŠ